Seed-Stage Venture Investing, 2nd Edition: An Insider’s Guide to Start-Ups for Scientists, Engineers, and Investors, © 2011 Thomson Reuters Westlawtakes a fresh look at the world of start-ups, focusing on life-science and technology spin-outs from academic and biomedical research centers. Co-authored by Bill Robbins and Jon Lasch, Ph.D., this book provides a substantial update to the previous edition (authored by Bill), explaining the current challenges of financing research-intensive academic spin-outs and offering new insights and advice about evaluating technology, navigating the technology transfer process, developing intellectual property, and applying for grant funding under the NIH SBIR Program. Focusing on real-world, practical information for academic faculty members, Ph.D. students, and post-docs, as well as business entrepreneurs, start-up managers, and new investors, Seed-Stage Venture Investing, 2nd Edition cuts to the chase, offering readers practical information not typically covered in graduate school courses on technology transfer and entrepreneurship.

About the Authors

William L. Robbins is the founder of Convergent Ventures and President of Convergent Management Inc., in Los Angeles. As an entrepreneur, start-up executive, and seed-stage investor, Mr. Robbins has worked with scientists, physicians, and engineers to create, fund, and manage life-science and  technology companies since the early 1990s. Currently, he focuses on general management, corporate strategy, and business development. He received his M.B.A. in marketing at Columbia Business School and his A.B. in psychology modified with biology at Dartmouth College.

Jonathan G. Lasch, Ph.D. is executive director of the Alfred E. Mann Institute for Biomedical Engineering (AMI) at the University of Southern California. He brings more than twenty-five years of experience in science and technology development and evaluation in the fields of biomedical instruments and systems, biotechnology, chemistry, and materials science. Dr. Lasch came to AMI from Convergent Ventures, a seed-stage venture investment and development company, where he served as managing director. He received his B.S. in biological science from the University of Texas at El Paso and his Ph.D. in chemistry from the University of Texas at Austin.

Where to Purchase Online

From the Publisher

Amazon

Barnes & Noble